Auro Laboratories Limited wishes to inform you that Ms. Shaan Jain has resigned from the post of Chief Financial Officer (KMP) of the Company with effect from December 18, 2024 due to personal Reason Further, their is no other material reason for resignation other than those mentioned in resignation letter, and the same is enclosed.

pdf

Auro Laboratories Ltd.

13 Nov 2024

246.30

-0.50%

Company Update

AURO LABORATORIES LTD. - 530233 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Auro Laboratories Limited has submitted the Newspaper Publication of the Financial Results for the Quarter and Half Year ended September 30, 2024.

pdf

Auro Laboratories Ltd.

11 Nov 2024

246.30

-0.50%

Result

AURO LABORATORIES LTD. - 530233 - Financial Results For The Quarter And Half Year Ended September …

BSE India

We wish to inform your that the Board of Directors of the Company in their Board Meeting dated November 11, 2024 approved the Un-audited Financial Results for the Quarter and Half year ended September 30, 2024.

pdf

Auro Laboratories Ltd.

05 Nov 2024

246.30

-0.50%

Board Meeting

AURO LABORATORIES LTD. - 530233 - Board Meeting Intimation for Approval Of Unaudited Financial Results For …

BSE India

AURO LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024 along with Limited Review Report and any other matter with the permission of the Chair.

pdf

Auro Laboratories Ltd.

20 Oct 2024

246.30

-0.50%

Company Update

AURO LABORATORIES LTD. - 530233 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 issued by the Registrar and Share Transfer Agent of the Company for the Quarter ended September 30, 2024.

pdf

Auro Laboratories Ltd.

01 Oct 2024

246.30

-0.50%

SAST

AURO LABORATORIES LTD. - 530233 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations,2015. We wish to inform you that the trading window for dealing in the securities of the company will remain close for all Designated Persons (as defined in the code) with effect from October 01, 2024 for the purpose of consideration of Unaudited Financial Results of the company for the quarter and half year ended September 30, 2024.

pdf

Auro Laboratories Ltd.

13 Aug 2024

246.30

-0.50%

Company Update

AURO LABORATORIES LTD. - 530233 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Auro Laboratories Limited has submitted the newspaper publication of Financial Results for the Quarter ended June 30, 2024.

pdf

Auro Laboratories Ltd.

09 Aug 2024

246.30

-0.50%

Result

AURO LABORATORIES LTD. - 530233 - Financial Results For The Quarter Ended June 30, 2024

BSE India

Pursuant to Regulation 30 & 33 of the SEBI(LODR), Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their Meeting held today (i.e. Friday, August 09, 2024) inter alia, considered and approved Unaudited Financials Results for the quarter ended June 30, 2024 along with Limited Review Report received from the Statutory Auditor of the Company.

pdf

Auro Laboratories Ltd.

31 Jul 2024

246.30

-0.50%

Board Meeting

AURO LABORATORIES LTD. - 530233 - Board Meeting Intimation for Unaudited Financial Results Of The Company …

BSE India

AURO LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 ,inter alia, to consider and approve 1. Unaudited Financial Results of the Company for quarter ended June 30, 2024 along with Limited Review Report thereon. 2. Any other matter with the permission of the Chair.

pdf

Is Auro Laboratories Ltd. worth buying?

51 Votes:

Buy 74.51%

Sell 13.73%

Hold 11.76%